Effector Mechanisms of CD8+ HLA-DR+ T Cells in Breast Cancer Patients Who Respond to Neoadjuvant Chemotherapy

SIMPLE SUMMARY: This study contributes to the characterization of CD8+ HLA-DR+ T cell mediated-mechanisms involved in the anti-tumor response in breast cancer patients who respond to neoadyuvant chemotherapy (NACT). Cultures with plasma from responder (R), but not from non-responder (NR), patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Osuna-Gómez, Rubén, Arqueros, Cristina, Galano, Carla, Mulet, Maria, Zamora, Carlos, Barnadas, Agustí, Vidal, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699550/
https://www.ncbi.nlm.nih.gov/pubmed/34944786
http://dx.doi.org/10.3390/cancers13246167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699550/
https://www.ncbi.nlm.nih.gov/pubmed/34944786
http://dx.doi.org/10.3390/cancers13246167

Ejemplares similares